Asia: Food, Drugs, Healthcare, Life Sciences

Ministerial Direction 105 allows the government to issue instructions to Home Affairs on how skilled visas should be prioritised, typically taking into account regional needs, sponsorship status and critical sectors.

The inquest into the death of Baby R highlighted issues regarding medical advice given over the course of the pregnancy and medical decision-making provided by attending midwives during the homebirth.

Migration formalities for foreign nationals in Kazakhstan require both the host party and the foreign national to follow a sequence of formal procedures. The purpose of stay of business immigrants, the existence of a proper legal basis for residence, timely notification of arrival, and compliance with the requirements applicable to conducting business activities are of significant importance for business immigrants.

The inquest into the death of Baby R highlighted issues regarding medical advice given over the course of the pregnancy and medical decision-making provided by attending midwives during the homebirth.

Patent applications for biomarkers in disease diagnosis are rapidly growing, yet many fail to meet patent law requirements. While screening experiments can identify correlations between biomarkers and diseases, they alone cannot prove diagnostic value. This analysis examines why validation experiments demonstrating sensitivity and specificity are essential for patent approval, and how their absence leads to rejection under Chinese Patent Law Articles 26(3) and 26(4).

For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers.

Finecure Pharmaceuticals adopted the mark "PANTOPACID" in 2007 for a competing Pantoprazole formulation and applied to register it in April 2009, claiming a portmanteau origin ("PANTO" + "P" for Proton Pump Inhibitor + "ACID"). Sun Pharma opposed this application in October 2010, and the opposition remains pending.

For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers.

Thailand's Food and Drug Administration has published its first consolidated list of substances that have completed safety assessments, including novel foods and non-novel ingredients. This development provides unprecedented transparency into regulatory precedents while raising important questions about data exclusivity and the scope of applicant-specific approvals in the evolving landscape of food innovation.